We are live on ! Find out more
ALIM

Alimera Sciences

Delisted

ALIM was delisted on the 13th of September, 2024.

46 hedge funds and large institutions have $50.1M invested in Alimera Sciences in 2013 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 19 increasing their positions, 9 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

111% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 9

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

2% more funds holding

Funds holding: 4546 (+1)

20% less capital invested

Capital invested by funds: $62.7M → $50.1M (-$12.6M)

Holders
46
Holders Change
+1
Holders Change %
+2.22%
% of All Funds
1.49%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
19
Reduced
9
Closed
4
Calls
$280K
Puts
Net Calls
+$280K
Net Calls Change
+$451K

ALIM Hedge Fund Activity: Q3 2013 in Review

46 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q3 2013, worth a combined $50.1M — down 20% from $62.7M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new ALIM positions and 4 closed out — a net gain of 1 holder — while 19 added to existing stakes and 9 trimmed.

The largest buyer was Columbia Wanger Asset Management, adding an estimated $699K. The largest seller was TFS Capital, exiting entirely with an estimated $171K sold.

  • 46 institutional investors held Alimera Sciences (ALIM) as of Q3 2013, up from 45 in Q2 2013.
  • Funds reported $50.1M of Alimera Sciences stock for Q3 2013, down 20% quarter-over-quarter.
  • 5 funds opened new Alimera Sciences positions in Q3 2013 and 4 closed out, a net change of +1 holder.
  • The largest Alimera Sciences buyer in Q3 2013 was Columbia Wanger Asset Management, an estimated $699K added.
  • The largest Alimera Sciences seller in Q3 2013 was TFS Capital, an estimated $171K sold.

Based on aggregated 13F filings for Q3 2013.